Soligenix
SNGX
#11002
Rank
S$9.33 M
Marketcap
S$0.43
Share price
0.51%
Change (1 day)
-75.76%
Change (1 year)

P/S ratio for Soligenix (SNGX)

P/S ratio as of November 2026 (TTM): N/A

According to Soligenix's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.36. At the end of 2023 the company had a P/S ratio of 9.36.

P/S ratio history for Soligenix from 2001 to 2023

PS ratio at the end of each year

Year P/S ratio Change
20239.36-54.53%
202220.6-40.05%
202134.3112.11%
202016.2137.68%
20196.81134.81%
20182.90-18.66%
20173.57204.72%
20161.17-70.95%
20154.0321.05%
20143.33-69.62%
201311.0414.17%
20122.13166.77%
20110.7988-96.21%
201021.127.96%
200916.5523.38%
20082.64-79.35%
200712.879.41%
20067.1455.4%
20054.59-82.98%
200427.0
2001> 1000

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Johnson & Johnson
JNJ
6.69N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
2.63N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
1.98N/A๐Ÿ‡ซ๐Ÿ‡ท France
Onconova Therapeutics
ONTX
92.5N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
10.4N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
2.87N/A๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Cleveland BioLabs
CBLI
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
0.4197N/A๐Ÿ‡บ๐Ÿ‡ธ USA